Ownership history in CITADEL ADVISORS LLC · 68 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in FRESENIUS MEDICAL CARE - ADR Receipt (FMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 28,489 | +17,389 | +156.7% | 0.00% | $679K | $23.82 |
| 2025 Q4 | REDUCED | 11,100 | -5,200 | -31.9% | 0.00% | $264K | $23.82 |
| 2025 Q3 | REDUCED | 16,300 | -46,233 | -73.9% | 0.00% | $429K | $26.33 |
| 2025 Q2 | ADDED | 62,533 | +47,533 | +316.9% | 0.00% | $1.8M | $28.57 |
| 2025 Q2 | ADDED | 15,000 | +14,994 | +249900.0% | 0.00% | $429K | $28.57 |
| 2025 Q1 | REDUCED | 6 | -33,994 | -100.0% | 0.00% | $149 | $24.21 |
| 2025 Q1 | REDUCED | 34,000 | -37,200 | -52.2% | 0.00% | $847K | $24.21 |
| 2025 Q1 | ADDED | 71,200 | +71,194 | +1186566.7% | 0.00% | $1.8M | $24.21 |
| 2024 Q4 | REDUCED | 6 | -23,894 | -100.0% | 0.00% | $136 | $22.01 |
| 2024 Q4 | REDUCED | 23,900 | -32,700 | -57.8% | 0.00% | $541K | $22.01 |
As of 2025 Q4 — sorted by position size